Latest Molecular biologists Stories
Precisely quantifying the amount of three different HER growth proteins, along with several other proteins believed linked to breast cancer, did not predict a patient's outcome after treatment for HER2-Positive Breast Cancer with Herceptin, say Mayo Clinic researchers.
Patients with HER2-positive breast cancer may have an alternative therapy when they develop resistance to trastuzumab, also known as Herceptin.
LA JOLLA, Calif., May 27, 2011 /PRNewswire-USNewswire/ -- The Royal Society announced today that Salk Institute molecular biologist Joanne Chory, Ph.D., an expert on how plants regulate their growth, has been named a foreign member of the Royal Society, the world's oldest scientific academy in continuous existence.
Using new genetic information, scientists have linked a commonly found human genetic variant with both longer telomeres and reduced risk of bladder cancer.
Dr. Bert O'Malley, chair of molecular and cellular biology at Baylor College of Medicine and the Tom Thompson Distinguished Service Professor of Molecular and Cellular Biology, is the 2011 recipient of the Ernst Schering Prize, which recognized his pioneering work on the actions of steroid hormones and nuclear receptors.
Positive psychological changes that occur during meditation training are associated with greater telomerase activity.
The story of the double helix's discovery has a few new twists.
Exercise can buffer the effects of stress-induced cell aging.